Hoth Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- February 22, 2018
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $3,000,000
Company Info
- Founders
- Robb Knie
- Company Description
- Hoth Therapeutics is a clinical-stage biopharmaceutical company focusing on developing new therapies for dermatological disorders.
- Market
- Patients suffering from atopic dermatitis (eczema)
- Location
- New York, Nevada, USA
- Coinvestors
- Laidlaw & Co.